Patents

Peptide sequences and other techniques that relate to RV001 and their use are protected by a family of patents derived from an international patent application (WO2009076966).

Patent application (PCT) filed on 18 December 2008. The table below presents the regions/countries that are covered by the company’s patents/applications and their status in that region. The company is continuously developing its family of patents.

Region/CountryStatusExpected Patent Expiry*
AustraliaGrantedDecember 2028
JapanGrantedDecember 2028
USAGrantedMarch 2032
EuropeGrantedDecember 2028
CanadaPending(December 2028 if granted)

* not including any patent term extension/supplementary protection certificate(s) that may be granted